Latest Insider Transactions at Astria Therapeutics, Inc. (ATXS)
This section provides a real-time view of insider transactions for Astria Therapeutics, Inc. (ATXS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Astria Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Astria Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Christopher Morabito Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$130,000
$13.59 P/Share
|
|
Apr 01
2024
|
Christopher Morabito Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.87 P/Share
|
|
Feb 01
2024
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,481,350
+33.74%
|
$29,776,200
$12.09 P/Share
|
|
Jan 29
2024
|
Christopher Morabito Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,200
-100.0%
|
$101,200
$11.15 P/Share
|
|
Jan 29
2024
|
Christopher Morabito Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,200
+50.0%
|
$27,600
$3.87 P/Share
|
|
Jan 26
2024
|
Christopher Morabito Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
800
-100.0%
|
$8,800
$11.02 P/Share
|
|
Jan 26
2024
|
Christopher Morabito Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+50.0%
|
$2,400
$3.87 P/Share
|
|
Dec 21
2023
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
740,000
+23.62%
|
$4,440,000
$6.2 P/Share
|
|
Oct 16
2023
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,074,608
+24.66%
|
$6,447,648
$6.51 P/Share
|
|
Dec 19
2022
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
908,265
+46.66%
|
$9,990,915
$11.01 P/Share
|
|
Nov 19
2021
|
Andrew Komjathy Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$600
$6.7 P/Share
|
|
Sep 20
2021
|
Jonathan Violin Director |
BUY
Other acquisition or disposition
|
Direct |
263,321
+50.0%
|
-
|
|
Sep 20
2021
|
Jonathan Violin Director |
SELL
Other acquisition or disposition
|
Indirect |
263,321
-100.0%
|
-
|